Literature DB >> 11731391

Access to infertility investigations and treatment in couples infected with HIV: questionnaire survey.

A Apoola1, J tenHof, P S Allan.   

Abstract

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  2001        PMID: 11731391      PMCID: PMC60302          DOI: 10.1136/bmj.323.7324.1285

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Ethical considerations in the treatment of infertility in women with human immunodeficiency virus infection.

Authors:  H Minkoff; N Santoro
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

2.  HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive.

Authors:  C Gilling-Smith; J R Smith; A E Semprini
Journal:  BMJ       Date:  2001-03-10

3.  Natural conception in HIV-negative women with HIV-infected partners.

Authors:  L Mandelbrot; I Heard; E Henrion-Géant; R Henrion
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

4.  Insemination of HIV-negative women with processed semen of HIV-positive partners.

Authors:  A E Semprini
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

5.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

  5 in total
  2 in total

1.  Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study.

Authors:  Mark H Yudin; Heather M Shapiro; Mona R Loutfy
Journal:  Reprod Health       Date:  2010-05-12       Impact factor: 3.223

Review 2.  Fathers and HIV: considerations for families.

Authors:  Lorraine Sherr
Journal:  J Int AIDS Soc       Date:  2010-06-23       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.